Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cost-Effectiveness Colors ACIP Decision On Hep B Vaccination For Diabetics

Executive Summary

The Centers for Disease Control’s Advisory Committee on Immunization Practices limited its Oct. 25 recommendation for vaccinating adult diabetics against hepatitis B to those under 60 years of age because of cost effectiveness considerations.

You may also be interested in...



Pfizer Touts Prevnar 13 Superiority As Initial Vaccine In Older Persons Before ACIP

Pfizer got to present a dry run of its case for Prevnar 13 as a superior initial vaccine for adults 50 and older to the Centers for Disease Control’s Advisory Committee on Immunization Practices Oct. 26.

Pfizer Touts Prevnar 13 Superiority As Initial Vaccine In Older Persons Before ACIP

Pfizer got to present a dry run of its case for Prevnar 13 as a superior initial vaccine for adults 50 and older to the Centers for Disease Control’s Advisory Committee on Immunization Practices Oct. 26.

IPAB Members Will Be Named In Time To Begin Recommendations In 2014, Sebelius Says

The White House has begun discussions with potential board member nominees, HHS secretary tells House Energy and Commerce Health Subcommittee.

Topics

UsernamePublicRestriction

Register

LL1125120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel